# A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

> **NCT04277598** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aposcience AG** · enrollment: 159 (actual)

## Conditions studied

- Diabetic Foot Ulcer (DFU)

## Interventions

- **BIOLOGICAL:** APO-2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04277598
- **Lead sponsor:** Aposcience AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-09
- **Primary completion:** 2023-12-06
- **Final completion:** 2023-12-06
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04277598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04277598, "A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04277598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*